 | Up a level |
Baughman, Robert P; Valeyre, Dominique; Korsten, Peter; Mathioudakis, Alexander G; Wuyts, Wim A; Wells, Athol; Rottoli, Paola; Nunes, Hiliaro; Lower, Elyse E; Judson, Marc A; Israel-Biet, Dominique; Grutters, Jan C; Drent, Marjolein; Culver, Daniel A; Bonella, Francesco; Antoniou, Katerina; Martone, Filippo; Quadder, Bernd; Spitzer, Ginger; Nagavci, Blin; ... (2021). ERS clinical practice guidelines on treatment of sarcoidosis. European respiratory journal, 58(6), p. 2004079. European Respiratory Society 10.1183/13993003.04079-2020
Noble, Paul W; Albera, Carlo; Bradford, Williamson Z; Costabel, Ulrich; Glassberg, Marilyn K; Kardatzke, David; King, Talmadge E; Lancaster, Lisa; Sahn, Steven A; Szwarcberg, Javier; Valeyre, Dominique; du Bois, Roland M; for the CAPACITY Study Group, incl.; Geiser, Thomas (2011). Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet, 377(9779), pp. 1760-1769. London: Elsevier 10.1016/S0140-6736(11)60405-4
